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Abstract: 
 
A series of tridentate pincer ligands, each possessing two sulfur- and one 
nitrogen-donor functionalities (SNS), based on bis-imidazole or bis-triazole salts were 
metallated with ZnCl2 to give new tridentate SNS pincer zinc(II) complexes 
[(SNS)ZnCl]+.   The zinc complexes serve as models for the zinc active site in Liver 
Alcohol Dehydrogenase (LADH) and were characterized with single crystal X-ray 
diffraction, 1H, 13C, and HSQC NMR spectroscopies, electrospray mass spectrometry, 
and elemental analysis.   The zinc complexes feature SNS donor atoms and 
pseudotetrahedral geometry about the zinc center, as is seen for liver alcohol 
dehydrogenase.  The bond lengths and bond angles of the zinc complexes correlate well 
to those in horse LADH. The SNS ligand precursors were characterized with 1H, 13C, and 
HSQC NMR spectroscopies, elemental analysis, and cyclic voltammetry, and were found 
to be redox active. Gaussian calculations were performed and agree with the 
experimentally observed oxidation potentials for the pincer ligand precursors.   The zinc 
complexes were screened for the reduction of electron-poor aldehydes in the presence of 
a hydrogen donor, 1-benzyl-1,4-dihydronicotinamide (BNAH), and it was determined 
that they enhance the reduction of electron-poor aldehydes.   The SNS zinc pincer 
complexes with bis-triazole ligand precursors exhibit higher activity for the reduction of 
4-nitrobenzaldehyde than do SNS zinc pincer complexes with bis-imidazole ligand 
precursors.  Quantitative stoichiometric conversion was seen for the reduction of 
pyridine-2-carboxaldehyde via SNS zinc pincer complexes with either bis-imidazole or 
bis-triazole ligand precursors.    	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1.  Introduction:   
 
The synthesis and characterization of complexes that attempt to mimic natural 
catalytic behavior have furthered the understanding of the enzymatic activity of 
metalloenzyme sites [1].  Model complexes are low molecular mass systems that 
replicate the metalloenzyme in terms of structures, ligand donor atoms, and oxidation 
states [2].  Nature is used as a model for the design of highly active and efficient 
catalysts, and is also the inspiration behind the synthesis of each model complex in order 
to investigate structures and functions of enzymes.   
Liver alcohol dehydrogenase (LADH) is a zinc metalloenzyme that catalyzes the 
oxidation of alcohols to aldehydes and ketones, and also catalyzes the reverse reaction, 
which is the reduction of a ketone or an aldehyde to an alcohol [1,3]. The crystal structure 
of horse LADH has been solved [4].  The resting enzyme includes one zinc(II) metal 
center, which is pseudo-tetrahedrally ligated with a labile water molecule and a so-called 
“SNS” ligand environment containing one N-histidine and two S-cysteine side chains.  
The nitrogen and sulfur atoms are provided by the histidine and cysteine residues of a 
single polypeptide chain [5].  Several LADH models have been previously reported with 
the same electron donor atoms as the metalloenzyme [6-13].    However, reactivity data 
was either not reported in some cases [14] or it was determined for zinc LADH model 
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complexes possessing donor atoms that are different than those within the enzyme’s 
active site [15].   
In a continuous effort to understand the catalytic activity of metalloenzymes, we have 
chosen to model the structure and reactivity of the zinc active site in LADH using a new 
and unique family of robust SNS pincer ligands.  First published in 1976, tridentate 
pincer ligands offer several advantages over monodentate ligands [16].  Primarily, 
tridentate pincer ligands offer favored metallation due to a less negative delta entropy of 
formation in comparison to monodentate ligands, which makes their metal complexes 
more stable [16].  Secondly, tridentate pincer ligands have been shown to inhibit 
dimerization of the metal complexes as a whole, a process that could possibly slow or 
inhibit catalytic activity [16, 17].  Thirdly, the conformational and electronic properties of 
tridentate ligands can be tuned by using different starting materials in their syntheses.  
Depending largely on the electron count of the metal center, tridentate pincer ligands can 
coordinate the metal atom in either a facial or meridional fashion [16, 17]. 
Pincer ligands have been utilized successfully in organometallic chemistry to prepare 
highly catalytically active and robust complexes [17]. The pincer ligand is an excellent 
system for use in modeling biological activity since the N-atom of pyridine, is sp2-
hybridized like that of histidine, and the thioimidazolyl S-donors have been reported by 
Parkin and Vahrenkamp to model thiol-derived ligands in bio-inspired zinc chemistry 
[18,19].   
 To the best of our knowledge, such tridentate pincer ligand systems have rarely been 
used in bio-inspired modeling chemistry. Our group has already had success in preparing 
tridentate SNS ligands that incorporate thione-substituted based imidazole functionalities 
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as well as zinc model complexes that contain these ligands [20].   The tridentate ligands 
used in these systems were relatively rigid as the pyridine and the imidazoles were 
directly bound to each other.  Further, in an effort to understand the presence and sterics 
of ancillary alkyl groups on the ability of this model system to reduce aldehydes, the 
ligands were prepared with imidazolyl rings having R groups of various sizes as shown in 
Figure 1.   
 
Figure 1:  Zinc-based SNS model complexes previously prepared by Miecznikowski 
et al. [20] 
In our current work, we seek to further our understanding of the catalytic nature of the 
zinc complexes by tuning the structure of tridentate SNS-pincer ligands.    Previously, we 
prepared somewhat rigid ligand systems through the use of 2,6-dibromopyridine as a 
ligand precursor.   Here, we use the starting material 2,6-(dibromomethyl)pyridine to 
introduce a methylene linker into the pincer ligand, thereby allowing us to examine the 
effect of ligand flexibility on substrate binding toward the goal of better understanding 
the catalytic activity of LADH.  In a similar vein, Crabtree and co-workers have shown 
that such a modification in Pd CNC-pincer complexes leads to improved catalytic activity 
in carbon-carbon bond formation reactions [21].  We expect to fine-tune further the 
electronic environment imparted by our ligand set through the use of imidazole- and 






R = iPr, neopentyl, n-butyl
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shown previously by Crabtree and Miecznikowski [22].    Furthermore, sulfur-substituted 
triazoline systems (1,2,4-triazolinethiones) have been prepared by others, so we have 
adapted their synthetic protocol for use in our current work [23]. 
   We therefore present here the syntheses, spectroscopic and electrochemical 
characterization, computational study, and activity screening of various tridentate SNS-
pincer complexes of zinc in which the ligand set is modified through the placement of a 
methylene linker between its pyridinyl and imidazolyl or triazolyl segments.   
  
2.  Experimental: 
2.1 General Procedures:   
All reagents used are commercially available and were used as received. 
Isopropyl imidazole, neopentyl imidazole, 1-isopropyl triazole, 1-n-butyl triazole, 1-
neopentyl triazole, 2,6-bis{[(n-butyl)-N´-methylene]imidazole}pyridine bromide, were 
prepared as reported previously [24-27].   BNA+ and BNAH were prepared as reported 
previously [28].   
NMR spectra were recorded at 25 °C on a Bruker Avance 300 MHz NMR 
spectrometer.  Spectra were referred to the solvent residual peak.  Electrospray mass 
spectrometry was performed on a Micromass ZQ instrument or a Varian LC-MS 
instrument using nitrogen as the drying and nebulizing gas.  Cyclic voltammetry 
experiments were performed using a Cypress Electroanalytical System with a silver wire 
reference electrode, a glassy carbon working electrode, and a platinum counter electrode.  
The supporting electrolyte for the cyclic voltammetry experiments was tetra-N-
butylammonium tetrafluoroborate.  The ferrocenium/ferrocene couple was used as an 
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internal reference; reduction potential values were corrected by assigning the 
ferrocenium/ferrocene couple to 0.40 V versus SCE.  When an inert atmosphere was 
needed, a M-Braun inert atmosphere glove box and standard Schlenk techniques were 
used with thoroughly degassed solvents. IR spectra were collected using a Thermo 
Nicolet AVATAR 380-FT-IR with a SMART SPECULATR reflectance adaptor.  C, H, 
N elemental analyses were performed by Atlantic Microlab Inc. (Norcross, GA).   
 
2.2 Crystallographic Analyses:   
Crystals of 1, 3, 5b, and 6 were mounted on a glass fiber or loop and placed in a -
80 oC nitrogen stream on a Bruker diffractometer equipped with a Smart CCD at Boston 
College (Chestnut Hill, MA).  Crystallographic data were collected using graphite 
monochromated 0.71073 Å Mo-Kα radiation and integrated and corrected for absorption 
using the Bruker SAINTPLUS software package [29].  The structures were solved using 
direct methods and refined using least-square methods on F-squared [30].  All other 
pertinent crystallographic details such as h, k, l ranges, 2θ ranges, and R-factors can be 
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Table 1.  Crystal and Structure Refinement Data for 1, 3, 5b, and 6 
 R = iPr (1) R = nBu (3) R = Np (5b) R = nBu (6) 
Formula C42H55Cl6N12S4Zn3 C42H56Cl6N10S4Zn3 C21H31N7S2 C38H54Cl6N14S4Zn4 
FW 
(g/mol) 
1265.02 1238.02 445.65 1380.33 
Temperat
ure (K) 
193(2) 193(2) 193(2) 193(2) 
Wavelen
gth (Å) 
0.71073 0.71073 0.71073 0.71073 
Crystal 
System 
Triclinic Monoclinic Triclinic Monoclinic 
Space 
Group 
P-1 P2(1)/c P2(1)/c P2(1)/c 
a (Å) 7.0010(19) 20.2931(8) 20.655(3) 23.7884(13) 
b (Å) 19.310(5) 21.6238(9) 11.2349(17) 11.0040(6) 
c (Å) 21.789(6) 13.2096(6) 10.6710(16) 21.1704(11) 
α (o) 70.872(8) 90 90 90 
β (o) 80.971(5) 107.064(2) 103.218(3) 99.770(3) 
γ (o) 79.577(5) 90 90 90 
Volume 
(Å)3 
2722.0(13) 5541.4(4) 2410.6(6) 5461.4(5) 
Z 4 8 4 8 
r (calc) 
(g/cm3) 
1.543 1.484 1.228 1.679 
Abs  
(mm-1) 
1.802 1.768 0.243 2.324 




0.20 x 0.10 x 0.10 0.10 x 0.08 x 0.08 0.20 x 0.20 
x 0.08 
0.08 x 0.06 x 0.05 
Theta 
Range (o) 
0.99 to 28.46 1.87 to 22.50 1.01 to 
28.26 
1.74 to 26.31 
Refl/Uniq 43409/13420 31379/7243 35218/5914 48222/11044 












Full Matrix least 
squares on F2 
Full Matrix least 




Full Matrix least 
squares on F2 
Data / 
restr / par 
13420 / 0 / 614 7243/0/562 5914 / 0 / 
277 
11044/ 0/ 639 
GOF on 0.868 1.018 0.627 0.971 





0.0450 0.0913 0.0488 0.0473 
wR2 0.0911 0.2159 0.1357 0.0822 
Peak/hole  
(e/Å-3) 
0.751 and -0.765 2.055 and -2.142 0.440 and -
0.256 
0.869 and -0.673 
 
 
2.3 Reactivity:   
In a typical reaction, 0.1 mmol of 4-nitrobenzaldehyde (or pyridine 2-
carboxaldehyde), 0.2 mmol of BNAH, and 0.1 mmol of the zinc complex or 0.2 mmol 
ZnCl2 were dissolved in 3 mL of CDCl3.  The reaction was heated at reflux.  Aliquots of 
the reaction were taken at certain times and analyzed using 1H NMR spectroscopy. All 
data are averages of at least two runs. 
 
2.4 Gaussian Calculations: 
Gaussian 03 was used to perform single-point calculations and DFT geometry 
optimizations using the B3LYP hybrid functional with 6-31G* basis sets as provided 
with the software [31]. Calculations were performed on the ligands alone with R = Me in 
all cases.  The structures of the ligands were first optimized in the gas phase as neutral 
and as cationic species under the Cs and C2 point groups.  Frequency analysis was 
performed on the optimized structures to determine whether or not they represented true 
minima.  Small imaginary frequencies on the order of ~ -10 cm-1 that are not indicative of 
transition-state structures were found only for the neutral structures of the thiotriazole 
systems having Cs symmetry.  Single-point SCRF calculations using DMSO via the 
CPCM solvent model were then performed using the “radii=uff” and “nosymmcav” 
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directives.  Oxidation potentials were computed by finding the difference in the total free 
energies in solution for the neutral and cationic species.  These ΔG values were then 
referenced to the absolute SCE potential in DMSO by subtracting 3.83V (the established 
correction to SHE in DMSO) and 0.241 V (the difference between SHE and SCE) [32]. 
 
 
2.5  Syntheses: 
Syntheses of ligand precursor bromide salts. 
As an example, a detailed description for the synthesis of 1a is given.  Detailed 
descriptions for the preparation of all the ligand precursor bromide salts are given in 
supporting information. 
2.5.1 Synthesis of 2,6-bis(N-isopropyl-N´-methyleneimidazole)pyridine bromide, 
(C19H27N5Br2):  [1a] 
 In a 100 mL round-bottom flask, 1.53g (5.78 mmol) 2,6-
bis(bromomethyl)pyridine was combined with 1.99 g (18.0 mmol) 1-isopropyl-1,3-
imidazole and dissolved in 10mL of 1,4-dioxane.  The solution was stirred at reflux 
overnight during which time, a brown precipitate formed.  The solid was collected with a 
Buchner funnel and washed with diethyl ether (3x, 30 mL each).  This solid was then 
taken up in methanol (10 mL) and precipitated in diethyl ether.  This solution was 
vacuum filtered and the solid product was washed with diethyl ether (3x, 30 mL each).  
Yield: 2.42 g (86.3%). Anal. Calc. for C19H27Br2N5 (485.26):  C, 47.03; H, 5.61; N, 
14.43.  Found:  C, 46.95; H, 5.74; N, 14.19.  
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1H NMR (DMSO-d6, 300 MHz) δ 9.47 (s, 2H, imidazole, CH), 7.98 (m, 3H, pyridine 
CH, and imidazole CH), 7.78 (d (3J = 1.8 Hz), 2H, imidazole CH), 7.49 (d (3J =7.5  Hz), 
2H, pyridine CH), 5.56 (s, 4H, CH2), 4.71 (m, 2H, isopropyl CH), 1.49 (d (3J = 6.9 Hz), 
12H, CH3).  13C {1H} NMR (DMSO-d6, 75 MHz), δ 153.65 (imidazole NCHN), 138.88 
(pyridine CH), 135.50 (pyridine Cipso), 123.30 (imidazole CH), 122.22 (pyridine CH), 
120.45 (imidazole CH), 52.69 (CH2), 52.30 (isopropyl CH), 22.32 (isopropyl CH3). 
 
2.5.2 Synthesis of 2,6-bis(N-neopentyl-N´-methyleneimidazole)pyridine bromide, 
(C23H35N5Br2): [2a]  
 Yield:   3.40 g (quantitative). Anal. Calc. for C23H35Br2N5•H2O (559.38):  C, 
49.38; H, 6.67; N, 12.52.  Found:  C, 49.07; H, 6.67; N, 12.34.   
1H NMR (DMSO-d6, 300 MHz) δ 9.33 (s, 2H, imidazole, CH), 7.99 (m, 1H, 
pyridine CH), 7.77 (d (3J = 1.5 Hz), 4H, imidazole CH), 7.46 (d (3J = 7.8 Hz), 2H, 
pyridine CH), 5.59 (s, 4H, CH2), 4.01 (s, 4H, neopentyl CH2), 0.92 (s, 18H, neopentyl 
CH3).  13C {1H} NMR (DMSO-d6, 75 MHz), δ 153.71 (pyridine Cipso), 138.90 (pyridine 
CH), 137.41 (imidazole CH), 123.77 (imidazole CH), 122.66 (imidazole CH), 122.02 
(pyridine CH), 59.45 (neopentyl CH2), 52.71 (CH2), 31.93 (neopentyl C(CH3)3), 26.63 
(neopentyl CH3). 
 
2.5.3 Synthesis of 2,6-bis(N-isopropyl-N´-methylenetriazole)pyridine bromide 
(C17H25N7Br2), [4a]:  
 Yield: 1.87g (94 %). Anal. Calc. for C17H25Br2N7 (487.24):  C, 41.91; H, 5.17; N, 
20.12.  Found:  C, 42.01; H, 5.19; N, 19.93.   
	   12	  
1H NMR (DMSO-d6, 300 MHz) δ 10.37 (s, 2H, triazole CH), 9.24 (s, 2H, triazole 
CH), 8.01 (m, 1H, pyridine CH), 7.62 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.69 (s, 4H, 
CH2), 4.87 (m, 2H, isopropyl CH), 1.56 (d (3J = 6.0 Hz), 12H, isopropyl CH3).  13C {1H} 
NMR (DMSO-d6, 75 MHz), δ 152.28 (triazole NCHN), 145.17 (triazole CH), 141.79 
(pyridine CH), 138.84 (pyridine Cipso), 122.51 (pyridine CH), 55.16 (CH2), 50.69 
(isopropyl CH), 21.15 (isopropyl CH3). 
 
2.5.4 Synthesis of 2,6-bis(N-neopentyl-N´-methylenetriazole)pyridine bromide 
(C21H33N7Br2) [5a]: 
Yield: 2.05g (quantitative).  Anal. Calc. for C21H33N7Br2•0.5 H2O  (543.34):  C, 45.66; 
H, 6.20; N, 17.75.  Found:  C, 45.48; H, 6.18; N, 17.69. 
1H NMR (DMSO-d6, 300 MHz) δ 10.43 (s, 2H, triazole, CH), 9.34 (s, 2H, 
triazole, CH), 8.04 (m, 1H, pyridine CH), 7.63 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.76 
(s, 4H, CH2), 4.31 (s, 4H, CH2), 0.96 (s, 18H, CH3). 13C{1H} NMR (DMSO-d6, 75 MHz), 
δ 152.37 (pyridine Cipso), 145.01 (triazole CH), 143.61 (triazole CH), 138.94 (pyridine 
CH), 122.52 (pyridine CH), 61.92 (CH2), 50.89 (CH2), 32.15 (neopentyl C(CH3)3), 26.72 
(neopentyl C(CH3)3). 
 
2.5.5 Synthesis of 2,6-bis[N-(n-butyl)-N´-methylenetriazole]pyridine bromide 
(C21H31N5Br2) [6a]: 
Yield:  1.11 g (quantitative). Anal. Calc. for C19H29Br2N7 •2H2O•CH3OH (515.29):  C, 
42.22, H, 6.58, N, 16.41.  Found:  C, 41.82; H, 6.09; N, 15.83. 
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1H NMR (DMSO-d6, 300 MHz) δ 10.30 (s, 2H, triazole, CH), 9.23 (s, 2H, triazole 
CH), 8.03 (m, 1H, pyridine CH), 7.61 (d (3J = 7.5 Hz), 2H, pyridine CH), 5.70 (s, 4H, 
CH2), 4.44 (t (3J = 7.2 Hz), 4H, n-butyl CH2), 1.87 (m, 4H, n-butyl CH2), 1.33 (m, 4H, n-
butyl CH2), 0.947 (m, 6H, n-butyl CH3).  13C {1H} NMR (DMSO-d6, 75 MHz), δ 152.30 
(pyridine CH), 145.31 (pyridine CH), 142.99 (triazole CH), 142.53 (triazole CH), 122.42 
(pyridine Cipso), 51.40 (CH2), 48.57 (n-butyl CH2), 30.01 (n-butyl CH2), 18.75 (n-butyl 
CH2), 13.28 (n-butyl CH3). 
 
Syntheses of Bis-thione ligand precursors: 
 
As an example, a detailed description for the synthesis of 1b is given.  Detailed 
descriptions for the preparation of all the bis-thione ligand precursors are given in 
supporting information. 
 
2.5.6   Synthesis of 2,6-bis(N-isopropyl-N´-methyleneimidazole-2-thione)pyridine 
(C19H25N5S2) [1b] 
 
In a round-bottom flask, 0.24 g (0.50 mmol) of 1a was added to 0.12 g (1.5 
mmol) of sodium acetate.  Acetonitrile (20 mL) was added to the solid mixture.  The 
reaction mixture was heated at reflux for a half hour during which, the solids dissolved in 
the acetonitrile.  To this solution, 0.34 g (11 mmol) of S8 and the mixture was heated at 
reflux for seven days.   Afterwards, the undissolved solid was filtered out of the mother 
liquor.  The solvent was evaporated off under reduced pressure.  The resulting product 
was oily. The product was dissolved in dichloromethane and was filtered to remove 
excess sodium acetate.  The solvent was removed under reduced pressure.  Yield: 0.13 g 
(70. %).  Anal. Calc. C19H25N5S2 •0.5H2O  (387.57): C, 57.54; H, 6.61; N, 17.66.  Found:  
C, 57.32; H, 6.37; N, 17.45. 
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1H NMR (DMSO-d6, 300 MHz) δ 7.73 (t (3J = 7.8 Hz), 1H, pyridine, CH), 7.31 (d (3J = 
2.7 Hz), 2H, imidazole CH), 7.22 (d (3J = 2.4 Hz), 2H, imidazole CH), 6.91 (d (3J = 7.8 
Hz), 2H, pyridine CH), 5.30 (s, 4H, CH2), 4.89 (m, 2H, isopropyl CH), 1.32 (d (3J = 6.9 
Hz), 12H, CH3).  13C{1H} NMR (DMSO-d6, 75 MHz), δ 160.92 (C=S), 155.80 (pyridine 
Cipso), 137.80 (pyridine CH), 120.08 (pyridine CH), 118.39 (imidazole CH), 114.03 
(imidazole CH), 51.15 (CH2), 48.41 (isopropyl CH), 21.14 (isopropyl CH3). Selected IR 
bands (reflectance):  vmax/cm-1 1129 (C=S). 
 
2.5.7 Synthesis of 2,6-bis(N-neopentyl-N´-methyleneimidazole-2-thione)pyridine 
(C23H33N5S2), [2b]: 
 
Yield:  0.26 g (60. %). Anal. Calc. C23H33N5S2 •3H2O  (443.67): C, 58.69; H, 
7.71; N, 14.88.  Found:  C, 58.86; H, 7.09; N, 14.79. 
1H NMR (DMSO-d6, 300 MHz) δ 7.30 (m, 1H, pyridine, CH), 7.22 (d (3J = 2.1 Hz), 2H, 
imidazole CH), 7.16 (d (3J = 2.1 Hz), 2H, imidazole CH), 6.86 (d 3J = 7.8 Hz, 2H, 
pyridine CH), 5.32 (s, 4H, CH2 linker), 3.92 (s, 4H, neopentyl CH2), 0.96 (s, 18H, 
neopentyl CH3), 13C{1H} NMR (DMSO-d6, 75 MHz), δ 163.54 (C=S), 155.93 (pyridine 
Cipso), 137.74 (pyridine CH), 119.68 (pyridine CH), 118.81 (imidazole CH), 117.55 
(imidazole CH), 57.03 (neopentyl CH2), 51.63 (CH2 linker), 33.63 (neopentyl C(CCH3)3), 
27.82 (neopentyl CH3). Selected IR bands (reflectance):  vmax/cm-1 1128 (C=S). 
 
2.5.8 Synthesis of 2,6-bis[N-(n-butyl)-N´-methyleneimidazole-2-thione]pyridine 
(C21H29N5S2) [3b]  
Yield:   0.10 g (23.%).  Anal. Calc. for C21H29N5S2 •H2O (415.62):  C, 58.17; H, 
7.21; N, 16.15.  Found:  C, 57.60; H, 6.66; N, 15.84.   
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1H NMR (DMSO-d6, 300 MHz) δ 7.73 (m, 1H, pyridine, CH), 7.21 (d (3J = 2.4 
Hz), 2H, imidazole CH), 7.19 (d (3J = 2.4 Hz), 2H, imidazole CH), 6.91 (d (3J = 7.8 Hz), 
2H, pyridine CH), 5.29 (s, 4H, CH2 linker), 3.98 (t (3J = 7.2 Hz), 4H, butyl CH2), 1.69 
(m, 4H, butyl CH2), 1.28 (m, 4H, butyl CH2), 0.94 (t (3J = 7.2 Hz), 6H, butyl CH3), 13C 
{1H} NMR (DMSO-d6, 75 MHz), δ 161.78 (C=S), 155.83 (pyridine Cipso), 137.78 
(pyridine CH), 119.97 (pyridine CH), 117.93 (imidazole CH), 117.64 (imidazole CH), 
51.35 (CH2 linker), 46.65 (butyl CH2), 30.93 (butyl CH2), 22.04 (butyl CH2), 13.54 (butyl 
CH3). Selected IR bands (reflectance):  vmax/cm-1 1129 (C=S). 
 
2.5.9 Synthesis of 2,6-bis(N-isopropyl-N´-methylenetriazole-2-thione)pyridine 
(C17H23N7S2) [4b] 
Yield: 0.31 g (78.%).  Anal. Calc. for C17H23N7S2•0.5H2O (389.54):  C, 51.23; H, 
6.07; N, 24.60.  Found:  C, 51.36; H, 5.92; N, 24.43.   
1H NMR (DMSO-d6, 300 MHz) δ 8.46 (s, 2H, triazole CH), 7.82 (t (3J = 7.8 Hz), 
1H, pyrdine CH), 7.26 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.28 (s, 4H, CH2), 4.92 (m, 
2H, isopropyl CH), 1.35 (d (3J = 6.6 Hz), 12H, isopropyl CH3).  13C{1H} NMR (DMSO-
d6, 75 MHz), δ 164.02 (C=S), 154.12 (pyridine Cipso), 141.33 (triazole CH), 137.95 
(pyridine CH), 121.10 (pyridine CH), 49.76 (isopropyl CH), 48.85 (CH2), 20.50 
(isopropyl CH3). Selected IR bands (reflectance):  vmax/cm-1 1158 (C=S). 
 
2.5.10 Synthesis of 2,6-bis(N-neopentyl-N´-methylenetriazole-2-thione)pyridine  
(C21H31N7S2), [5b]: 
 
 Yield 0.42 g (82 %). Off-white crystals of 5b that were suitable for X-ray 
diffraction were grown by allowing diethyl ether to slowly diffuse into a solution of 5b in 
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acetonitrile. Anal. Calc. for C21H31N7S2 •0.5 CH2Cl2:  C, 52.90; H, 6.61; N, 20.09.  
Found:  C, 52.54, H, 6.45, N, 20.40.   
1H NMR (DMSO-d6, 300 MHz) δ 8.50 (s, 2H, triazole CH), 7.82 (m, 1H, pyridine CH), 
7.21 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.29 (s, 4H, CH2), 3.99 (s, 4H, neopentyl CH2),  
0.91 (s, 18H, neopentyl CH3). 13C{1H} NMR (DMSO-d6, 75 MHz), δ 167.66 (C=S), 
155.08 (pyridine Cipso), 142.00 (triazole CH), 138.84 (pyridine CH), 121.69 (pyridine 
CH), 59.23 (neopentyl CH2 linker), 50.21 (CH2 linker) 34.51 (C(CH3)3), 28.64 (C(CH3)3). 
Selected IR bands (reflectance):  vmax/cm-1 1144 (C=S). 
2.5.11 Synthesis of 2,6-bis[N-(n-butyl)-N´-methylenetriazole-2-thione]pyridine 
(C19H29N7S2Br2) [6b] 
Yield 0.17 g (46 %).  Anal. Calc. for C19H27N7S2 •0.5 H2O (417.59):  C, 53.49; H, 
6.62; N, 22.98.  Found:  C, 53.45, H, 6.55, N, 22.13.   
1H NMR (DMSO-d6, 300 MHz) δ 8.47 (s, 2H, triazole CH), 7.80 (m, 1H, pyrdine 
CH), 7.24 (d (3J = 2.4 Hz), 2H, pyridine CH), 7.23 (d (3J = 2.7 Hz), 2H, pyridine CH), 
5.27 (s, 4H, CH2), 4.11 (t 7.24 (d (3J = 4.8 Hz), 2H, pyridine CH), 4H, n-butyl CH2),  
1.74 (m, 4H, n-butyl CH2), 1.28 (m, 4H, n-butyl CH2), 0.900 (t (3J = 4.8 Hz), 6H, n-butyl 
CH3).   13C{1H} NMR (DMSO-d6, 75 MHz), δ 165.10 (C=S), 154.09 (pyridine Cipso), 
141.35 (triazole CH), 137.95 (pyridine CH), 120.94 (pyridine CH), 49.05 (CH2 linker), 
47.99 (n-butyl CH2), 29.56 (n-butyl CH2), 19.04 (n-butyl CH2), 13.44 (n-butyl CH3). 
Selected IR bands (reflectance):  vmax/cm-1 1149 (C=S). 
 
Syntheses of Zinc Complexes: 
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As an example, a detailed description for the synthesis of 1 is given.     Detailed 




2.5.12 Synthesis of chloro-(η3-S,S,N)-[2,6-bis(N-isopropyl-N´-methyleneimidazole-2-
thione)pyridine]zinc (II) tetrachlorozincate [C42H55Cl2N12S4Zn2][ZnCl4] [1] 
In a round-bottom flask, 0.13 g (0.34 mmol) of 1b was combined with 0.098 g 
(0.72 mmol) of ZnCl2 and dissolved in 10 mL of dichloromethane.  The solution mixture 
was refluxed for 20 h.  After this time, the solvent was removed under reduced pressure. 
Yield: 0.22 g (quantitative).  White single crystals for X-ray diffraction were grown by a 
slow vapor diffusion of diethyl ether into an acetonitrile solution containing the zinc 
complex.   Anal. Calc. for C19H27Cl4N5OS2Zn2 (678.15):  C, 33.65; H, 4.01; N, 10.33.  
Found:  C, 33.58, H, 3.95, N, 10.54.   
1H NMR (DMSO-d6, 300 MHz) δ 7.73 (m, 1H, pyridine CH), 7.31 (d (3J = 2.7 
Hz), 2H, imidazole CH), 7.22 (d (3J = 2.4 Hz), 2H, imidazole CH), 6.90 (d (3J = 7.5 Hz), 
2H, pyridine CH), 5.30 (s, 4H, CH2), 4.88 (m, 2H, isopropyl CH) 1.30 (d (3J = 6.6 Hz), 
12H, isopropyl CH3). 13C{1H} NMR (DMSO-d6, 75 MHz), δ 160.88 (C=S), 155.83 
(pyridine Cipso), 137.85 (pyridine CH), 120.10 (pyridine CH), 118.45 (imidazole CH), 
114.09 (imidazole CH), 51.18 (CH2), 48.45 (isopropyl CH), 21.30 (isopropyl CH3).  
1H NMR (MeOH-d4, 300 MHz) δ 7.91 (t (3J = 7.8 Hz), 1H, pyridine CH), 7.45 (d 
(3J = 7.8 Hz), 2H, pyridine CH), 7.32 (m, 4H, imidazole CH), 5.54 (s, 4H, CH2), 4.97 (m, 
2H, isopropyl CH) 1.40 (d (3J = 4.2 Hz), 12H, isopropyl CH3).  
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2.5.13 Synthesis of chloro-(η3-S,S,N)-[2,6-bis(N-neopentyl-N´-methyleneimidazole-2-
thione)pyridine]zinc (II) aquatrichlorozincate [C23H33N5S2ClZn][ZnCl3(OH2)]  [2] 
Yield: 0.30 g (quantitative). The white product was purified dissolving the 
complex into acetonitrile and allowing diethyl ether vapor to diffuse in to the acetonitrile 
solution slowly.  Anal. Calc. for C23H35Cl4N5OS2Zn2 •2 H2O (734.26):  C, 35.86; H, 
5.10; N, 9.09.  Found:  C, 35.60, H, 4.89, N, 8.99.   
1H NMR (DMSO-d6, 300 MHz) δ 7.73 (m, 1H, pyridine CH), 7.21 (d (3J = 2.4 
Hz), 2H, imidazole CH), 7.15 (d (3J = 2.4 Hz), 2H, imidazole CH), 6.84 (d (3J = 7.8 Hz), 
2H, pyridine CH), 5.31 (s, 4H, CH2), 3.91 (s, 4H, CH2), 0.95 (s, 18H, CH3).  13C{1H} 
NMR (DMSO-d6, 75 MHz), δ 163.70 (C=S), 156.01 (pyridine Cipso), 137.70 (pyridine 
CH), 119.85 (pyridine CH), 118.83 (imidazole CH), 117.57 (imidazole CH), 57.04 
(neopentyl CH2), 51.64 (CH2), 33.64 (neopentyl C(CH3)3), 27.83 (neopentyl CH3).  
1H NMR (MeOH-d4, 300 MHz) δ 7.90 (t (3J = 7.8 Hz), 1H, pyridine CH), 7.42 (d 
(3J = 7.5 Hz), 2H, pyridine CH), 7.26 (AB doublet (3J = 1.8 Hz), 2H, imidazole CH), 7.18 
(AB doublet (3J = 1.8 Hz), 2H, imidazole CH), 5.60 (s, 4H, CH2), 4.01 (s, 4H, CH2), 1.01 
(s, 18H, CH3). 
 
2.5.14 Synthesis of chloro-(η3-S,S,N)-{2,6-bis[N-(n-butyl)-N´-methyleneimidazole-2-
thione]pyridine}zinc (II)] tetrachlorozincate [C42H56Cl2N10S4Zn2][ZnCl4]  [3] 
Yield: 0.11 g (quantitative).   Off-white single crystals for X-ray diffraction were 
grown by a slow vapor diffusion of diethyl ether into a methanol solution containing the 
zinc complex.   Anal. Calc. for C42H58Cl6N10S4Zn3 •2 H2O (1240.09):  C, 39.53; H, 4.90; 
N, 10.98.  Found:  C, 39.60, H, 4.80, N, 10.85.  
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1H NMR (DMSO-d6, 300 MHz) δ 7.72 (m, 1H, pyridine CH), 7.22 (d (3J = 2.4 
Hz), 2H, imidazole CH), 7.19 (d (3J = 2.4 Hz), 2H, imidazole CH) 6.89 (d (3J = 7.8 Hz), 
2H, pyridine CH), 5.28 (s, 4H, CH2), 3.97 (t (3J = 7.5 Hz), 4H, n-butyl CH2), 1.68 (m, 
4H, n-butyl CH2), 1.29 (m, 4H, n-butyl CH2), 0.903 (t (3J = 7.2Hz), 6H, n-butyl CH3). 
13C{1H} NMR (DMSO-d6, 75 MHz), δ 161.79 (C=S), 155.82 (pyridine Cipso), 137.77 
(pyridine CH), 119.96 (pyridine CH), 117.95 (imidazole CH), 117.65 (imidazole CH), 
51.35 (CH2), 46.65 (n-butyl CH2), 30.37 (n-butyl CH2), 19.11 (n-butyl CH2), 13.55 (n-
butyl CH3).  
1H NMR (MeOH-d4 300 MHz) δ 7.90 (m, 1H, pyridine CH), 7.47 (d (3J = 7.8 
Hz), 2H, pyridine CH), 7.28 (AB doublet (3J = 2.1 Hz), 2H, imidazole CH) 7.23 (AB 
doublet (3J = 2.4 Hz), 2H, imidazole CH), 5.54 (s, 4H, CH2), 4.11 (t (3J = 7.5 Hz), 4H, n-
butyl CH2), 1.79 (m, 4H, n-butyl CH2), 1.38 (m, 4H, n-butyl CH2), 0.98 (t (3J = 7.5Hz), 
6H, n-butyl CH3). 
 
2.5.15 Synthesis of chloro-(η3-S,S,N)-[2,6-bis(N-isopropyl-N’-methylenetriazole-2-
thione)pyridine]zinc(II) aquatrichlorozincate  [C17H23N7S2ZnCl][ZnCl3(H2O)] [4] 
Yield: 0.24 g (quantitative).  The white product was precipitated by a slow vapor 
diffusion of diethyl ether into an acetonitrile solution containing the zinc complex.   Anal. 
Calc. for C17H25Cl4N7OS2Zn2 •1 H2O (680.13):  C, 29.25; H, 3.90; N, 14.04.  Found:  C, 
29.04 H, 3.64, N, 13.59.  
1H NMR (DMSO-d6, 300 MHz) δ 8.44 (s, 2H, triazole CH), 7.81 (m, 1H, pyridine 
CH), 7.25 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.27 (s, 4H, CH2), 4.91 (m, 2H, isopropyl 
CH), 1.33 (d (3J = 6.6 Hz), 12H, isopropyl CH3).  13C{1H} NMR (DMSO-d6, 75 MHz), δ 
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164.02 (C=S), 154.11 (pyridine Cipso), 141.34 (triazole CH), 137.96 (pyridine CH), 
121.11 (pyridine CH), 49.77 (isopropyl CH), 48.85 (CH2),  20.50 (isopropyl CH3).  
1H NMR (MeOH-d4, 300 MHz) δ 8.24 (s, 2H, triazole CH), 7.78 (t (3J = 7.5 Hz), 
1H, pyridine CH), 7.34 (d (3J = 7.5 Hz), 2H, pyridine CH), 5.32 (s, 4H, CH2), 5.05 (m, 
2H, isopropyl CH), 1.38 (d (3J = 4.8 Hz) , 12H, isopropyl CH3). 13C{1H} NMR (MeOH-
d4, 75 MHz) δ 165.55 (C=S), 155.48 (Cipso), 142.29 (CH triazole), 139.15 (CH pyridine), 
122.98 (CH pyridine), 51.88 (CH isopropyl), 50.47 (CH2), 20.99 (CH3 isopropyl) 
 
2.5.16 Synthesis of chloro-(η3-S,S,N)-[2,6-bis(N-neopentyl-N´-methylenetriazole-2-
thione)pyridine]zinc(II) trichlorozincate ([C21H31N7S2ZnCl][ZnCl3]), [5]: 
Yield:  0.25g (quantitative).  The product was purified by precipitation by 
dissolving the product in methanol and allowing for a slow vapor diffusion of diethyl 
ether into the methanol solution.   Anal. Calc. for C21H31Cl4N7OS2Zn2 •CH3OH (718.22):  
C, 35.22; H, 4.70; N, 13.07.  Found:  C, 35.90 H, 5.20, N, 13.73.  
1H NMR (DMSO-d6, 300 MHz) δ 8.49 (s, 1H, triazole CH), 7.81 (m, 1H, pyridine 
CH), 7.19 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.28 (s, 4H, CH2), 3.98 (s, 4H, neopentyl 
CH2), 0.97 (s, 18H, neopentyl CH3).  13C{1H} NMR (DMSO-d6, 75 MHz), δ 166.75 
(C=S), 154.18 (pyridine Cipso), 141.10 (triazole CH), 137.95 (pyridine CH), 120.80 
(pyridine CH), 58.33 (neopentyl CH2), 49.31 (CH2), 33.61 (C(CH3)3), 27.75 (CH3).  
1H NMR (MeOH-d4, 300 MHz) δ 8.24 (s, 1H, triazole CH), 7.78 (t (3J = 7.5 Hz), 
1H, pyridine CH), 7.32 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.33 (s, 4H, CH2), 4.05 (s, 4H, 
neopentyl CH2), 1.02 (s, 18H, neopentyl CH3). 13C{1H} NMR (MeOH-d4, 75 MHz), δ 
168.46 (C=S), 155.51 (pyridine Cipso), 141.93 (triazole CH), 139.12 (pyridine CH), 
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122.77 (pyridine CH), 60.27 (neopentyl CH2), 50.89 (CH2), 34.90 (C(CH3)3), 28.44 
(CH3). 
 
2.5.17 Synthesis of chloro-(η3-S,S,N)-{2,6-bis[(N-(n-butyl)-N´-methylenetriazole-2-
thione]pyridine}zinc(II) bis(µ-chlorodichlorozincate)  ([C38H54N14S4Zn2Cl2][Zn2Cl6]  
[6] 
Yield:  0.28 g (quantitative).  Crystals suitable for X-ray diffraction analysis were 
grown by allowing diethyl ether vapor to slowly diffuse into a solution of 6 in methanol.  
Anal. Calc. for C19H29Cl4N7OS2Zn2 • H2O •CH3OH (708.18):  C, 31.68; H, 4.65; N, 
12.93.  Found:  C, 31.51, H, 4.06, N, 12.57. 
1H NMR (DMSO-d6, 300 MHz) δ 8.45 (s, 2H, triazole CH), 7.81 (m, 1H, pyridine 
CH), 7.23 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.26 (s, 4H, CH2), 4.09 (t (3J = 6.9 Hz), 4H, 
n-butyl CH2), 1.73 (m, 4H, n-butyl CH2), 1.28 (m, 4H, n-butyl CH2), 0.90 (t (3J = 7.2 Hz), 
6H, n-butyl CH3). 13C{1H} NMR (DMSO-d6, 75 MHz), δ 165.11 (C=S), 154.09 (pyridine 
Cipso), 141.36 (pyridine CH), 137.95 (triazole CH), 120.95 (pyridine CH), 49.06 (CH2), 
48.00 (n-butyl CH2), 29.57 (n-butyl CH2), 19.05 (n-butyl CH2), 13.45 (n-butyl CH3).  
1H NMR (MeOH-d4, 300 MHz) δ 8.22 (s, 2H, triazole CH), 7.78 (m, 1H, pyridine 
CH), 7.33 (d (3J = 7.8 Hz), 2H, pyridine CH), 5.31 (s, 4H, CH2), 4.18 (t (3J = 7.2 Hz), 4H, 
n-butyl CH2), 1.82 (m, 4H, n-butyl CH2), 1.36 (m, 4H, n-butyl CH2), 0.97 (t (3J = 7.5 Hz), 
6H, n-butyl CH3). 13C{1H} NMR (MeOH-d4 75 MHz), δ 166.68 (C=S), 155.40 (pyridine 
Cipso), 142.29 (pyridine CH), 139.13 (triazole CH), 122.79 (pyridine CH), 50.62 (CH2), 
49.96 (n-butyl CH2), 31.16 (n-butyl CH2), 20.68 (n-butyl CH2), 13.97 (n-butyl CH3). 
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3. Results and Discussion: 
3.1 Syntheses and Spectroscopy 
The syntheses of the tridentate SNS ligand precursors and zinc complexes 1 - 6 were 
accomplished following Scheme 1. Different R groups were employed because Crabtree 
has reported that modification of such substituents affects the solubility and catalytic 
activity of the metal complexes [25]. The alkyl imidazoles or alkyl triazoles were 
prepared either by following known routes or were commercially available [24-27].    
These compounds react with 2,6-bis(bromomethyl)pyridine in 1,4-dioxane to form  
ligand precursor salts, 1a - 6a, that are soluble in DMSO, methanol, acetonitrile and 
water [20, 28]. 
Compounds 1a - 6a react with a mild base, sodium acetate, and elemental sulfur in 
refluxing acetonitrile to form bis-thione ligand precursors 1b - 6b [24].  As determined 
by NMR spectroscopy, compounds 1b - 6b can be purified by filtering a dichloromethane 
solution containing this compound through alumina. The bis-thione ligand precursors are 
soluble in DMSO, dichloromethane, chloroform, acetone, acetonitrile, and methanol.  
Off-white crystals of 5b that were suitable for X-ray diffraction were grown by allowing 
diethyl ether to slowly diffuse into a solution of 5b in acetonitrile. 
The bis-thione ligand precursors subsequently react with ZnCl2 in refluxing CH2Cl2 to 
afford zinc complexes 1 - 6.  The driving force for the metallation is the formation of zinc 
complexes 1-6, which are sparingly soluble in CH2Cl2.  Off-white crystals that were 
suitable for X-ray diffraction were grown by allowing diethyl ether vapor (1, 3, and 6) to 
slowly diffuse into an acetonitrile (1) or methanol (3 or 6) solution containing the zinc 
complex.  All of the reactions could be carried out in air, and proceeded in yields at or 
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above 63 %. The zinc complexes 1-6 are soluble in DMSO, acetonitrile, methanol, and 
water and are sparingly soluble in dichloromethane and chloroform.  Complexes 4-6 were 
more soluble in MeOH-d4 than were 1-3.  
	  
Scheme 1:  Preparation of 1-6 
 
Ligand precursors 1a – 6a and 1b – 6b and zinc complexes 1-6 were characterized 
using 1H, 13C, and HSQC NMR spectroscopy.   For all compounds, only one set of 
resonances was detected indicating that the two halves of each molecule are symmetry-
related.   The 13C NMR of 1b - 3b and of 4b - 6b, show resonances at δ ~162 ppm and δ 
~166 ppm, respectively, that are consistent with C=S formation [17].  The ligand 
precursors 1a – 6a contain a resonance at δ ~11 ppm in their 1H NMR spectra indicative 
of an acidic C-H proton whereas this feature is absent in the spectra of compounds 1b – 













R =  iPr, neopentyl, nBu
2 Br-
1, X = CH, R = iPr, 63 %
2, X = CH, R = neopentyl, quant.
3, X = CH, R = nBu, quant.
4, X = N, R = iPr, quant.
5, X = N, R = neopentyl, quant.








1a, X= CH, R = iPr, 86 %
2a, X= CH, R = neopentyl, quant.
3a, X= CH, R = nBu
4a, X = N, R = iPr, 94 %
5a, X = N, R = neopentyl, quant.
6a, X = N, R = nBu, quant.
1b, X = CH, R = iPr, 70. %
2b, X = CH, R = neopentyl, 60. %
3b, X = CH, R = nBu, 23 %
4b, X = N, R = iPr, 78 %
5b, X = N, R = neopentyl, 82 %
6b, X = N, R = nBu, 45 %
BrBr
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Attenuated total reflectance IR spectra were collected for 1b – 6b.   The C=S stretch 
occurs at 1128 to 1129 cm-1 for the bis-imidazole bis-thione precursors (1b-3b) and at 
1144 to 1158 cm-1 for the bis-triazole bis-thione systems, 4b – 6b.   This data is 
consistent with the triazole compounds having stronger C=S bonds.  
Complexes 1-6 were analyzed with 1H, 13C, and HSQC NMR spectroscopy in DMSO-
d6.   The 1H and 13C NMR of the zinc complexes are identical to the respective ligand 
precursors 1b – 6b, with very little shift in the resonances.  This was expected since no 
hydrogen or carbon atoms are displaced or added upon metallation with zinc(II) chloride. 
In addition, the 1H NMR spectra of complexes 1-6 were acquired in a less polar and 
weakly coordinating solvent, MeOH-d4, to verify that the SNS pincer ligands are not 
displaced from the coordination sphere of zinc.  Electrospray mass spectrometry data, 
described below, also verifies this result.  Zinc complexes 4-6 are more soluble than zinc 
complexes 1-3 in MeOH-d4.  We were able to prepare NMR samples of complexes 4-6 
that were concentrated enough in MeOH-d4 so that we could acquire a 13C NMR 
spectrum of these complexes. In the 1H NMR spectra that were acquired in MeOH-d4 for 
complexes 1-3, when compared to the 1H NMR spectra acquired in DMSO-d6, the 
resonances generally shifted at least δ 0.10 ppm upfield.   For complexes 1-3, the 
pyridine CH doublet shifted at least δ 0.55 ppm upfield in the proton NMR spectra that 
were acquired in MeOH-d4, when compared to the 1H NMR spectra acquired in DMSO-
d6. In the 1H NMR spectra that were acquired in MeOH-d4 for complexes 4-6, when 
compared to the 1H NMR spectra acquired in DMSO-d6, some of the resonances shifted 
upfield and others shifted downfield.    The 13C NMR resonances for complexes 4-6 
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shifted at least δ 0.4 ppm upfield in MeOH-d4 when compared to the spectra obtained in 
DMSO-d6. 
ESI-MS spectra for compounds 1-6 were collected with cone voltages of 0 V and 70 
V.  The predominant feature in the spectra of these systems at the higher cone voltage is 
that of the fully ligated zinc complex, indicating that the compound is stable and 
suggesting that it is unlikely that the ligand is displaced when dissolved in a polar 
solvent.   In negative ion mode, the expected m/z values were seen for [ZnCl3]-.  The 
isotopic patterns in the mass spectrometry data fit the assigned structures. 
 
3.2 X-ray Crystallography 
The solid-state molecular structures of 1, 3, 5b, and 6 are shown in Figures 2-5, 
respectively.    Analogous to the LADH structure, complexes 1, 3, and 6 feature a zinc 
atom that is tetrahedrally coordinated.  These complexes also feature SNS donor atoms 
and pseudotetrahedral geometry about the zinc center, as is seen for liver alcohol 
dehydrogenase. The bond lengths and bond angles compare reasonably well to the active 
site of horse LADH enzyme bound to NADH  (Table 2) [33].  
The carbon-sulfur bond lengths for 1, 3, and 6 were between 1.65 – 1.70 Å (Table 2).  
These bond lengths are between what is normally associated with a C-S single bond, 1.83 
Å, and a C=S double bond, 1.61 Å [34].  For 1 and 3, the counter-anion is [ZnCl4]2- and 
for 6, the counter ion is  [Zn2Cl6]2-.   The counter-ion is seen even when either one or two 
molar equivalents of ZnCl2 are used in the preparation of 1-6.   In complex 1, two 
molecules of acetonitrile co-crystallized within the unit cell.  The R-factor for 3 was 0.09 
and was higher than the R-factor reported for 1, 5b, or 6 (Table 1).   The higher R-factor 
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Figure 2.  Solid-state structure of complex 1. 
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(3) 
Figure 3.  Solid-state structure of complex 3. 
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(5b) 
Figure 4.  Solid-state structure of complex 5b. 
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Table 2.  Selected bond lengths and angles (esd) for 1, 3, and 6 with comparison to 
LADH-NADH [33]. 
 R = iPr (1) R = nBu (3) R = nBu (6) LADH-
NADH 
Zn(1) – N(1) 
(Å) 
2.107(3) 1.972(11) 2.057(4) 2.15 
Zn(1) – Cl(1) 
(Å) 
2.2249(13) 2.219(5) 2.2500(12)  
Zn(1) – S(1) 
(Å) 
2.3387(14) 2.321(4) 2.3541(14) 2.32 
Zn(1) – S(2) 
(Å) 
2.3510(14) 2.321(4) 2.3277(14) 2.23 
S(1) – C(1) (Å) 1.700(4) 1.650(12) 1.702(5)  
N(3) – Zn(1) – 
Cl(1) 
107.50(10) 99.0(4) 100.39(10)  
N(3) – Zn(1) – 
S(1) 
109.76(10) 125.0(5) 115.04(11) 105 
Cl(1) – Zn(1) – 
S(1) 
114.24(5) 118.6(2) 111.22(5)  
N(3) – Zn(1) – 
S(2) 
114.37(10) 100.3(4) 115.71(11) 114 
Cl(1) – Zn(1) – 
S(2) 
109.55(4) 115.25(16) 113.36(5)  
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S(1) – Zn(1) – 
S(2) 
101.54(5) 99.16(15) 101.62(5) 130 
 
 Various parameters of the Gaussian 03-optimized structures for the ligands 
compare favorably with the crystal structure determined for compound 5b (Figure 4).  In 
particular, the calculated C=S bond lengths of 1.675 Å (X=N and R = CH3) and 1.683 Å 
(X = CH and R = CH3) are quite close to those found for 5b (1.677 Å and 1.667 Å).  
Similarly, the N-N bond length calculated for the triazole ligand (1.375 Å) matches that 
determined for 5b (1.385 Å) as do the C-NN (1.362 Å vs. 1.353 Å, respectively) and the 
C-NCH2 (1.390 Å vs. 1.373 Å, respectively) bond lengths.  The use of B3LYP/6-31G* 
method to model the electrochemical behavior of this ligand as discussed in the following 
section of this report is therefore justified.   
 
3.3 Cyclic Voltammetry of Ligand Precursors and Comparison of Cyclic Voltammetry 
Results to Gaussian Calculations. 
Compounds 1b and 5b were studied by cyclic voltammetry in DMSO as part of 
their characterizations.  The cyclic voltammogram for 1b (Figure 6) shows oxidation 
waves at 976 and 1339 mV (the latter caused most likely by solvent degradation) while 
the cyclic voltammogram for 5b (Figure 7) has a wave at 1178 mV.  The oxidation waves 
are broad and are located at the same potential across consecutive scans, indicating the 
stability of the ligands with respect to repeated oxidation and reduction.  To understand 
the nature of this electrochemical feature, we chose to perform quantum mechanical 
calculations using Gaussian 03. 
	   32	  
 
Figure 6.  Cyclic Voltammogram of 1b in DMSO (2mM) with 0.2 M TBAF.  The scan 
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Figure 7.  Cyclic Voltammogram of 5b in DMSO (2mM) with 0.2 M TBAF.  The scan 
rate was 100 mV/s with ferrocene (E1/2 = 400 mV) used as an internal standard. 
 
The Gaussian calculations performed as part of this study agree quite well with 
the experimentally observed oxidation potentials for the pincer ligand and shed light on 
how the degree of through-space interaction of the thioimidazole/thiotriazole rings can 
impact the observed oxidation potential.  The ΔG oxidation potentials for the solvated 
bis-thioimidazole system are calculated to be 0.828 V with the ligand structure 
constrained to Cs symmetry and 1.234 V under C2 symmetry.  For the bis-thiotriazole 
compound, the calculated oxidation potentials are 1.178 V (Cs) and 1.716 V (C2).  For 
both ligands, the oxidation potential determined under Cs symmetry correlates well with 
the experimentally determined value, with that calculated for the triazole system 
matching the experimental value exactly.  Also of note is the relative oxidation potentials, 
both calculated and experimentally determined, between the thioimidazole and 
thiotriazole systems.  Replacement of a C-H unit in the imidazolyl ring with a more 
electronegative N atom causes the oxidation to become more difficult by ca. 200 mV. 
The imposition of Cs symmetry on the ligand forces the thione-containing rings to 
stack while under the C2 point group, the thioimidazole/thiotriazole rings are located on 
opposite sides of the connecting pyridine ring.  For reference, the optimized structures of 
the neutral Cs- and C2-symmetry structures are presented in Figure 8.  Of particular note 
is the sulfur-sulfur distance between the two rings, which for the neutral optimized 
structures is 6.97Å for the Cs structure and 10.22Å for the C2 system.  For the cations, the 
S-S distance under the Cs point group decreases considerably to 3.03Å while it remains 
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largely the same (10.15Å) for the C2 structure.  Examination of a contour plot of the 
HOMO for the bis-thioimidazole system, shown in Figure 9, explains this observation.  
This orbital contains S, N, and C π character and is located entirely on the thioimidazole 
rings, with a considerable amount of the orbital character residing on the S atoms in a σ* 
fashion between the sulfurs.  Removal of an electron from this orbital acts to decrease the 
S-S repulsive nature of this orbital, which explains the more than halving of the S-S 
distance observed in the geometry optimizations upon oxidation of this system.  Similar 
systems are known to form disulfides upon oxidation [35], which leads us to conclude 
that inclusion of a strong S-S interaction through the imposition of the Cs point group is 
essential for an acceptable computational modeling of the oxidation potential.  We also 
note that this interaction, permitted by the flexibility allowed through the introduction of 
the methylene linkers, leads to an oxidation that is approximately 300 mV easier than we 
observed in our previous report. [20] 
 
 






Figure 8.  Optimized structures of thioimidazole systems having Cs (top) and C2 (bottom) 
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Figure 9.  Contour plot of bis-thioimidazole ligand HOMO as viewed from above the 
pyridinyl ring.  This orbital contains π-type character on the thioimidazole rings with a 
σ*-like interaction between the p orbitals on the S atoms as seen in the bottom portion of 
this contour plot. 
 
3.5 Reactivity 
With an established synthetic protocol for these metalloenzyme models and a greater 
understanding of their structural characteristics, our attention was turned to probing their 
stoichiometric activity.   Zinc complexes 1-6 were screened for activity through the 
reduction of 4-nitrobenzaldehyde, an electron-poor aldehyde, in the presence of a 
hydrogen donor, 1-benzyl-1,4-dihydronicotinamide (BNAH) (eq. 1).	  	  BNAH was 
prepared following a known literature procedure and is the reagent of choice to model 
NADH [28].  1H NMR was used to follow the disappearance of the aldehyde proton (δ 
10.2 ppm) and the shifting of the aromatic C-H protons in the alcohol product (δ 8.24 
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ppm).  The aromatic proton resonances of the C-H protons in the alcohol product were 
spectroscopically distinct from the other product or starting materials resonances and no 
overlap of 1H NMR resonances was observed.  For all reactivity experimentation, 0.1 
mmol of aldehyde, 0.1 mmol zinc precursor or 0.2 mmol of ZnCl2, and 0.2 mmol BNAH 
were used.  Control reactions with ZnCl2 were performed using two equivalents of this 
salt because complexes 1-6 contain two zinc ions (one in the cation and one in the anion) 
per neutral compound.   Product formation was detected by 1H NMR by comparison with 
authentic material.  In no case was there any indication of reduction of nitro substituents.     











1, R = iPr
2, R = neopentyl
3, R = nBu
4, X = N, R = iPr
5, X = N, R = neopentyl
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Table 3.  Reactivity Data for 1-6 
Entry Zn Complex Time Conversion (%) 
1 None 20h < 5 
2 2b (bis thione ligand 
precursor) 
20h < 5 
3 ZnCl2 (2 eq.) 5h 15 
4 ZnCl2 a (2 eq.) 20h 13 
5 ZnCl2  (2 eq.) 20h 18 
6 1 20h 32 
7 2 20h 23 
8 3 20h 25 
9 4 20h 37 
10 5 20h 45 
11 6 20h 59 
12 ZnCl2 (10 eq.) 20h 42 
a	   Reaction was run under an N2 environment.  The reaction was setup in an inert 
atmosphere glove box. 
 
As shown in Table 3, zinc complexes 1-6 enhance the rate of the reaction for the 
reduction of 4-nitrobenzaldehyde when compared to that for either ZnCl2 or ligand 
precursor.  Mechanistically, others have proposed a hydrogen atom transfer between the 
co-factor and the substrate upon coordination to the zinc active site based upon a 
previously reported mechanism for LADH offered by Berreau and co-workers [36].  
Entries 3-5 in Table 3 indicate that ZnCl2 reacts stoichiometrically with electron-poor 
aldehydes such as 4-nitrobenzaldhyde to yield alcohol product to a small extent (ca. 18 % 
conversion).  We therefore propose that Zn2+ acts as a Lewis acid catalyst in the reaction 
where ZnCl2 is utilized.  It is plausible that the Zn2+ in the counteranion contributes to the 
reactivity that is shown for 1-6 in Table 3. Experiments are underway to prepare 
tridentate zinc SNS pincer complexes with a counter-anion that does not contain a zinc 
ion.   We also wondered if an excess of ZnCl2 would enhance the rate of conversion of 4-
nitrobenzaldehyde.  We saw 42 % conversion of 4-nitrobenzaldehyde after 20 h when 
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excess ZnCl2 (10 eq) was used.    Thus, an excess of ZnCl2 and BNAH could also be used 
to reduce 4-nitrobenzaldehyde.  
Reactivity data for imidazole complexes with the CH2 linker is consistently lower 
when compared to previous studies carried out without the CH2 linker [20] when 
identical ligand groups were tested.  Imidazole compounds with isopropyl wingtip R 
groups without the CH2 linker gave a catalytic activity of 42% compared to 32% when 
the CH2 linker compound was tested.  Similarly, the zinc complexes with neopentyl 
wingtip groups and no CH2 linker had a greater turnover (48 %) than did the analogous 
compound with a methylene linker (23 %), and the zinc complexes with n-butyl wingtip 
groups and no CH2 linker had a greater turnover (33 %) and the identical compounds 
with a CH2 linker (25 %).  
Based on the data presented in Table 3, it appears that the choice of the alkyl group is 
important as n-butyl and neopentyl groups (bis-triazole) gave a higher percent conversion 
than isopropyl.  Previous experimentation without the CH2 linker supported the claim that 
isopropyl wingtips yielded the greatest catalytic activity due to the fact that larger R 
groups such as n-butyl are more sterically demanding, when compared to neopentyl or 
isopropyl, and may shield the zinc metal center from interacting with BNAH and 
substrate.    The opposite trend was observed for both imidazole and triazole complexes 
with the CH2 linker.  Perhaps added room for binding provided by the CH2 linker reduces 
the wingtip effects previously observed.  Furthermore, the larger R group complexes gave 
the greatest solubility.  The identity of the wingtip group is therefore a crucial variable to 
consider when screening metal complexes for activity [22].   
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The choice of azole rings also is important as CH2 linker complexes with the triazole 
ring gave consistently greater catalytic activity for the reduction reaction than identical R 
group imidazole complexes.   The system with the greatest catalytic efficiency was 
complex 6 (59 %), which contains triazole rings that possess n-butyl wingtip groups.   
We also tried to reduce another electron-poor aldehyde, pyridine-2-carboxaldehyde, in 
the presence of a stoichiometric amount of 1-6 or ZnCl2 (eq. 2). 1H NMR was used to 
follow the disappearance of the aldehyde proton (δ 10.2 ppm) and the appearance of the 
aromatic C-H protons in the alcohol product (δ 8.4 ppm). The aromatic proton resonance 
of the alcohol product did not overlap with the 1H NMR resonances of either the starting 
materials or the products or the zinc complex. Table 4 illustrates the reactivity data for 1-
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Table 4.  Reactivity Data for 1-6 for the reduction of pyridine-2-carboxaldehyde. 
Entry Zn Complex Time Conversion (%) 
1 None 20h < 5 
2 ZnCl2 20h 19 
3 1 20h Quantitative 
4 2 20h Quantitative 
5 3 20h Quantitative 
6 4 20h Quantitative 
7 5 20h Quantitative 
8 6 20h Quantitative 
 
As shown in Table 4, zinc complexes 1-6 enhance the rate of the reaction for the 
reduction of pyridine-2-carboxaldehyde when compared to ZnCl2.   Use of complexes 1-6 
results in quantitative conversion of pyridine-2-carboxyaldehyde to pyridin-2-ylmethanol. 
As seen in Tables 3 and 4, enhancement for the reduction of 4-nitrobenzaldehyde or 
pyridine-2-carboxaldehyde was observed for complexes 1-6.  Stoichiometric conversion 
to the alcohol product was observed for pyridine-2-carboxaldehyde.  Based on the 
mechanism proposed by Berreau and co-workers [36], the low activity of complexes 1-6 
for the reduction of 4-nitrobenzaldehyde could be due to the slow hydrogen transfer 
between the co-factor and the substrate, which is coordinated to the zinc active site.  
More importantly, the alcohol product may inhibit the reaction.  As the alcohol is formed, 
it may coordinate to the zinc metal center as the reaction progresses, and thereby hinder 
the reaction. 
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4.  Conclusions: 
A series of Zn(II) compounds containing the SNS facial coordination of a 
tridentate pincer ligand were prepared and characterized. The tridentate SNS pincer 
ligand precursors and zinc complexes used in this work have provided new insights in the 
field of bioinorganic modeling chemistry.   The zinc complexes serve as models for the 
zinc active site in liver alcohol dehydrogenase.  The SNS zinc pincer complexes adopt a 
pseudo-tetrahedral geometry and have a SNS coordination environment about the zinc 
center like LADH and react with BNAH to reduce electron-poor aldehydes.   The zinc 
complexes reported herein react with BNAH to quantitatively reduce pyridine-2-
carboxaldehyde.    The zinc complexes reported also reduce 4-nitro-benzaldehyde. It 
remains a challenge to synthesize a neutral zinc complex with a tridentate ligand with 
SNS donor atoms that yield reactivity that is comparable to LADH.  
DFT calculations were performed to examine various structural and electronic 
properties of these compounds.  The computed oxidation potentials match well with what 
is observed experimentally while the calculated reduction potential indicates that the 
experimental reduction wave does not correspond to a simple one-electron reduction of 
the ligand precursor without other reactivity occurring.  
 
Supporting Information: 
The 1H, 13C and HSQC NMR spectra of 1a, 2a, 4a-6a, 1b-6b, and 1-6 and mass spectra 
of 1-6 are provided. IR spectra for 1b-6b and crystallographic details of 1, 3, 5b, and 6 
are also given.  The detailed descriptions for the syntheses of each compound are given as 
well.   




A series of tridentate SNS ligand precursors, based on bis-imidazole and bis-triazole 
precursors, were metallated with ZnCl2 to give new tridentate SNS pincer zinc complexes 
that serve as models for the zinc active site in Liver Alcohol Dehydrogenase (LADH).  
These systems were characterized with single crystal X-ray diffraction, 1H, 13C, and 
HSQC NMR spectroscopies, and electrospray mass spectrometry, and were studied by 
density functional theory.  The ability of these compounds to catalyze the reduction of 















• Synthesized and characterized a series of SNS Zn(II) pincer compounds  
• Zn(II) complexes enhance reduction of aldehydes in presence of hydrogen donor 
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